Skip to main content

and
  1. No Access

    Article

    Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party

    Little is known about the prognostic impact of prior paclitaxel therapy and response to induction chemotherapy defined as the regimen preceding high-dose chemotherapy (HDCT) for the salvage therapy of advanced...

    A Necchi, R Miceli, M Bregni, C Bokemeyer, L A Berger in Bone Marrow Transplantation (2016)

  2. Article

    Open Access

    Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

    High circulating tumor cell (CTC) counts are associated with poor prognosis in advanced prostate cancer, and recently CTC number was suggested to be a surrogate for survival in metastatic castrate-resistant pr...

    C. R. Lindsay, S. Le Moulec, F. Billiot, Y. Loriot, M. Ngo-Camus, P. Vielh in BMC Cancer (2016)

  3. Article

    Erratum: hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway

    Correction to: Oncogene (2006) 25, 4505–4514; doi:10.1038/sj.onc.1209487; published online 17 April 2006 Errors were inadvertently included in Figure 3a of the article mentioned above. In particular, represent...

    C Massard, Y Zermati, A-L Pauleau, N Larochette, D Métivier, L Sabatier in Oncogene (2013)

  4. No Access

    Article

    hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway

    hTERT is the catalytic subunit of the telomerase and is hence required for telomerase maintenance activity and cancer cell immortalization. Here, we show that acute hTERT depletion has no adverse effects on th...

    C Massard, Y Zermati, A-L Pauleau, N Larochette, D Métivier, L Sabatier in Oncogene (2006)